Filing Details
- Accession Number:
- 0001127602-14-023958
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-28 16:35:34
- Reporting Period:
- 2014-07-24
- Filing Date:
- 2014-07-28
- Accepted Time:
- 2014-07-28 16:35:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1222674 | B John Ziegler | C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-07-24 | 6,135 | $49.94 | 22,960 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-24 | 6,135 | $61.90 | 16,825 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-07-25 | 1,865 | $49.94 | 18,690 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-07-25 | 1,865 | $61.90 | 16,825 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2014-07-24 | 6,135 | $0.00 | 6,135 | $49.94 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2014-07-25 | 1,865 | $0.00 | 1,865 | $49.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,865 | 2015-05-16 | No | 4 | M | Direct | |
0 | 2015-05-16 | No | 4 | M | Direct |
Footnotes
- This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 20, 2014.
- The options vested in three annual installments beginning with the first on May 16, 2009, the second on May 16, 2010 and the final on May 16, 2011.